From Medscape Education Oncology

Podcast Series: Emerging Practice Patterns in Clinical Oncology

About This Series

Recent advances in our understanding of targeted therapies and personalized treatment planning have led to the advent of novel treatment approaches in various malignancies, including prostate, thyroid, and colorectal cancers, sarcoma, and lymphoma. With the rapid expansion of available and emerging treatment paradigms, clinicians are challenged to keep up to date with the most recent information. This 6-episode podcast series aims to help the interprofessional care teams collectively improve the lives of patients who live with cancer.

Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma CME / ABIM MOC

Dr Nastoupil and Dr Dreyling discuss PI3K inhibition in follicular lymphoma, including practical considerations and treatment selection.

0.25_{ABIM MOC}0.25_CME
Personalizing Progressive Metastatic CRC Treatment CME / ABIM MOC

Dr Grothey and Dr Denlinger discuss advances in biomarkers and personalized treatment of patients with metastatic CRC.

0.25_{ABIM MOC}0.25_CME
Targeted Alpha Therapies in Prostate Cancer CME / ABIM MOC

Join Dr Ryan and Dr George as they discuss the use of targeted alpha radiopharmaceuticals in treating mCRPC.

0.25_{ABIM MOC}0.25_CME
Treatment Advances in NTRK Gene Fusion-Positive Sarcoma: What Do You Need to Know? CME / ABIM MOC

Dr Demetri and Dr Blay discuss the treatment landscape in NTRK fusion-positive sarcoma.

0.25_{ABIM MOC}0.25_CME
Expert Perspectives on the Management of Advanced Thyroid Cancer: What's New? CME / ABIM MOC

Join Dr Brose and Dr Wirth as they discuss developments in targeted therapy for advanced thyroid cancer.

0.25_{ABIM MOC}0.25_CME
Prostate Cancer: A PSA on nmCRPC Updates CME / ABIM MOC

Dr Ryan and Dr Shore discuss second-generation antiandrogen therapies and survival updates in key clinical trials.

0.25_{ABIM MOC}0.25_CME